---
title: "Sharma East India Hosp and Medical Research Ltd (524548) — Share Price, Financials & Analysis"
symbol: "524548"
company: "Sharma East India Hosp and Medical Research Ltd"
canonical: "https://tapetide.com/stocks/524548"
isin: "INE465H01012"
nse_symbol: "SHARMAEASTINDIAHOSPITALLTD"
bse_code: "524548"
sector: "Healthcare Services"
industry: "Healthcare Service Provider"
market_cap_cr: 31.53
generated_at: "2026-09-13T20:15:56.794Z"
---

# Sharma East India Hosp and Medical Research Ltd (524548)

Canonical page: https://tapetide.com/stocks/524548

## Company

- **NSE Symbol:** SHARMAEASTINDIAHOSPITALLTD
- **BSE Code:** 524548
- **ISIN:** INE465H01012
- **Sector:** Healthcare Services
- **Industry:** Healthcare Service Provider
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2024-07-04
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** jaipurhospital.co.in

## About

Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:50:30.222223Z.

- **Market Cap:** ₹31.53 Cr
- **Classification:** Microcap
- **P/E (reported):** 25
- **EPS (reported):** ₹2.02
- **Book Value:** ₹39.15
- **Price to Book:** 2.31
- **Dividend Yield:** 0%
- **ROE:** 9.97%
- **ROCE:** 15.36%
- **Debt to Equity:** 0.53
- **Revenue (yearly):** ₹35.93 Cr
- **Net Income:** ₹1.14 Cr
- **EBITDA:** ₹3.64 Cr
- **52-Week High:** ₹207.35
- **52-Week Low:** ₹80.15
- **RSI (14):** 39.16

## Tapetide Score

- **Score:** 43 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 22.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 31.11 | 9% |
| growth | 57.38 | 9% |
| momentum | 46.11 | 12% |
| ownership | 50 | 24% |
| quality | 39.67 | 22% |
| valuation | 38.51 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Company has a low return on equity of -5.61% over last 3 years.
- Debtor days have increased from 82.3 to 116 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 692.04% | 422.66% | 377.86% |
| ebitda margin growth | -10% | -23.21% | -29.93% | -25.48% |
| net income growth | -25% | -5% | 14% | 21% |
| revenue growth | 44% | 18.97% | 20% | 35% |
| roce | — | -0.13% | -3.27% | 14.89% |
| roe | — | 68.98% | 7.92% | 39.44% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 5.36 | 5.85 | 1.8 | 6.72 | 9.02 | 8.15 | 5.98 | 9.47 | 9.38 | 9.61 | 7.47 | 10.76 |
| Expenses | 4.62 | 4.95 | 6.13 | 5.86 | 7.91 | 7.29 | 5.17 | 8.55 | 8.44 | 8.85 | 6.46 | 9.9 |
| Operating Profit | 0.74 | 0.9 | -4.33 | 0.86 | 1.11 | 0.86 | 0.81 | 0.92 | 0.94 | 0.76 | 1.01 | 0.86 |
| OPM % | 13.81 | 15.38 | -240.56 | 12.8 | 12.31 | 10.55 | 13.55 | 9.71 | 10.02 | 7.91 | 13.52 | 7.99 |
| Other Income | 0 | 0 | 5.31 | 0 | 0.04 | 0.04 | 0.23 | 0.04 | 0.05 | 0.05 | 0.02 | 0.04 |
| Interest | 0.22 | 0.31 | 0.14 | 0.17 | 0.25 | 0.15 | 0.14 | 0.11 | 0.1 | 0.13 | 0.16 | 0.19 |
| Depreciation | 0.34 | 0.35 | 0.46 | 0.35 | 0.44 | 0.36 | 0.67 | 0.42 | 0.43 | 0.43 | 0.44 | 0.36 |
| Profit before tax | 0.18 | 0.24 | 0.38 | 0.34 | 0.46 | 0.39 | 0.23 | 0.43 | 0.46 | 0.25 | 0.43 | 0.35 |
| Tax % | -61.11 | 0 | 89.47 | 26.47 | 26.09 | 25.64 | -60.87 | 25.58 | 28.26 | 28 | 0 | 25.71 |
| Net Profit | 0.29 | 0.23 | 0.04 | 0.25 | 0.34 | 0.29 | 0.37 | 0.32 | 0.32 | 0.18 | 0.43 | 0.26 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 16 | 14.73 | 16.17 | 8.13 | 17.04 | 20.73 | 18.52 | 29.87 | 35.93 | 37.22 |
| Expenses | 14.54 | 14.09 | 14.24 | 8.79 | 14.79 | 17.43 | 20.4 | 26.21 | 32.3 | 33.65 |
| Operating Profit | 1.46 | 0.64 | 1.93 | -0.66 | 2.25 | 3.3 | -1.88 | 3.66 | 3.63 | 3.57 |
| OPM % | 9.12 | 4.34 | 11.94 | -8.12 | 13.2 | 15.92 | -10.15 | 12.25 | 10.1 | 9.59 |
| Other Income | 0.07 | 1.11 | 0.03 | 2.83 | 0.06 | 0.06 | 5.31 | 0.31 | 0.16 | 0.16 |
| Interest | 0.73 | 0.88 | 1.15 | 0.69 | 0.7 | 1.18 | 0.95 | 0.72 | 0.51 | 0.58 |
| Depreciation | 0.62 | 0.52 | 0.43 | 0.65 | 0.78 | 1.39 | 1.48 | 1.84 | 1.72 | 1.66 |
| Profit before tax | 0.18 | 0.35 | 0.38 | 0.83 | 0.83 | 0.79 | 1 | 1.41 | 1.56 | 1.49 |
| Tax % | 27.78 | 22.86 | 18.42 | 24.1 | 18.07 | -5.06 | 34 | 12.06 | 20.51 | — |
| Net Profit | 0.13 | 0.27 | 0.31 | 0.64 | 0.68 | 0.83 | 0.66 | 1.24 | 1.24 | 1.19 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 |
| Reserves | 3.32 | 3.46 | 3.73 | 4.12 | 4.76 | 5.44 | 6.41 | 7.07 | 8.32 | 9.56 |
| Borrowings | 7.51 | 5.38 | 10.89 | 7.42 | 5.98 | 4.35 | 8.3 | 5.04 | 2.26 | 7.29 |
| Other Liabilities | 2.65 | 3.28 | 3.35 | 4.16 | 3.98 | 5.11 | 4.84 | 8.89 | 12.94 | 11.91 |
| Total Liabilities | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 27.68 | 32.92 |
| Fixed Assets | 6.4 | 6.07 | 4.73 | 4.41 | 5.51 | 6.85 | 9.1 | 7.7 | 9.37 | 8.45 |
| CWIP | 0 | 0.01 | 0.35 | 1.74 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1.79 | 1.79 | 1.8 | 1.89 | 1.89 | 1.89 | 2.05 | 2.05 | 2.05 | 2.05 |
| Other Assets | 9.45 | 8.41 | 15.25 | 11.82 | 11.48 | 10.32 | 12.56 | 15.41 | 16.26 | 22.42 |
| Total Assets | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 27.68 | 32.92 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.82 | 3.12 | -1.43 | 1.21 | 1.4 | 2.03 | 1.28 | -1.13 | 6.69 | -3.86 |
| Cash from Investing Activity | -0.77 | -0.25 | 1.65 | -1.5 | 2.79 | -2.11 | -3.63 | 5.17 | -3.26 | -0.65 |
| Cash from Financing Activity | -0.08 | -2.8 | 4.74 | -4.74 | -2.16 | -1.78 | 2.77 | -4.2 | -3.5 | 4.52 |
| Net Cash Flow | -0.03 | 0.06 | 4.96 | -5.03 | 2.03 | -1.86 | 0.41 | -0.17 | -0.06 | 0.01 |
| Free Cash Flow | 0.05 | 2.86 | 0.22 | -0.29 | 4.19 | -0.09 | -2.36 | 4.01 | 3.35 | -4.66 |
| CFO/OP | 53 | 218 | -212 | 66 | -232 | 96 | 39 | 45 | 189 | -95 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 49.4 | 74.14 | 85.49 | 107.22 | 120.32 | 72.61 | 75.54 | 50.85 | 79.92 | 116.21 |
| Inventory Days | — | 98.98 | — | — | 217.45 | 49.38 | 41.71 | 225.64 | 211.14 | 81.39 |
| Days Payable | — | 143.83 | — | — | 481.49 | 390.76 | 304.84 | 1659.09 | 418.28 | 102.76 |
| Cash Conversion Cycle | 49.4 | 29.29 | 85.49 | 107.22 | -143.72 | -268.77 | -187.59 | -1382.61 | -127.23 | 94.85 |
| Working Capital Days | 20.87 | 18.71 | -75.08 | 46.5 | 48.04 | 35.99 | -2.64 | -115.89 | 2.69 | 15.64 |
| ROCE % | 8.6 | 6.5 | 1.57 | 8.87 | -8.3 | 10.61 | 12 | -18.61 | 12.77 | 11.58 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 33.5% | 33.5% | 32.83% | 32.83% | 32.92% | 33.49% | 33.5% | 33.5% | 33.49% | 33.31% | 33.33% | 33.33% |
| Others | 12.86% | 12.86% | 13.53% | 13.53% | 13.44% | 12.87% | 12.86% | 12.86% | 12.88% | 13.06% | 13.03% | 13.03% |
| No. of Shareholders | 3698 | 3698 | 3698 | 3697 | 3778 | 3967 | 4068 | 4147 | 4377 | 4226 | 4210 | 4211 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 7 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 93.58 | Sell |
| EMA (10) | 93.17 | Sell |
| SMA (20) | 94.38 | Sell |
| EMA (20) | 94.37 | Sell |
| SMA (50) | 97.37 | Sell |
| EMA (50) | 96.86 | Sell |
| SMA (100) | 100.19 | Sell |
| EMA (100) | 100.05 | Sell |
| SMA (200) | 107.11 | Sell |
| EMA (200) | 103.16 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.77 | Neutral |
| MACD (12,26,9) | -1.54 | Sell |
| Stochastic (14,3,3) | 23.35 | Neutral |
| ADX (14) | 13.66 | Neutral |
| Williams %R (14) | -70.45 | Neutral |
| ATR (14) | 5.69 | High Volatility |
| ROC (12) | -0.81 | Sell |
| Stoch RSI (14) | 58.55 | Neutral |
| UO (7,14,28) | 35.21 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Tuesday September 08 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=387a4089-721b-4a23-bfdf-1ead8f07a738.pdf) |
| 2026-09-08 | [Notice Of 37Th Annual General Meeting Schedule To Be Held On 30Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91896363-455f-46ce-b970-9979be568391.pdf) |
| 2026-09-08 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7736304f-6991-4d57-96e2-0f4a43e0303a.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1271c4a-4b4d-4dc4-88e3-2b0e56157625.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Approval Of Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa0c8185-cf52-4ff1-a23c-290d983a05b6.pdf) |
| 2026-08-04 | [Board Meeting Intimation for Approval Of IND-AS Compliant Standalone Un-Audited Financial Results For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53516337-82c0-48b0-9f4c-ddd43cc19357.pdf) |
| 2026-07-09 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f00ac5e-b16f-4029-870d-e663d05f7478.pdf) |
| 2026-06-22 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44b9cb6e-f294-44b6-bde1-0a2fb4eb08d4.pdf) |
| 2026-06-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1b93036-3456-4eef-9799-a2e43d1d5156.pdf) |
| 2026-05-30 | [Board Meeting Outcome for Outcome Of Board Meeting Held On May 30 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations. 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44749cf7-2c04-426d-9475-f2d354c0ee28.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Approval Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9231e0c4-c10a-45d3-8b1a-a94e7fa03560.pdf) |
| 2026-05-31 | [Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=981140e2-6236-4385-83dd-7824700262be.pdf) |
| 2026-02-14 | [Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20e5f5a4-edbb-46cd-9ab1-573005f3942a.pdf) |
| 2025-11-14 | [Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8652efd-e60d-4d16-8cf7-5a9c28135489.pdf) |
| 2025-08-08 | [Approval Of Standalone Unaudited Financial Results For The Quarter Ended 30Th June 2025 Along With Limited Review Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84048e8d-6e08-462a-8806-723f30d7b7be.pdf) |
| 2025-05-23 | [Approval Of Standalone Audited Financial Results Quarter And Year Ended On 31St March 2025 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7395156-2c00-4e49-8dc8-415b4a1ecb56.pdf) |
| 2025-01-10 | [Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e7cc502-edb0-4c88-91a0-5f8b35553959.pdf) |
| 2024-11-14 | [Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ce7b1d3-b44b-40dd-92c1-5ee865026803.pdf) |
| 2024-08-13 | [Approval Of Financial Results For The Quarter Ended 30Th June 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6ada1a9-9192-4c43-9173-fa88253c36a1.pdf) |
| 2024-06-01 | [Results-Delay in Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a96576c0-136d-4e42-9946-14483c1c673e.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 January 2026 - RTA certificate under SEBI Reg 74(5) for quarter ended 31-Dec-2025; no rematerialisation requests. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 January 2026 - RTA certificate under SEBI Reg 74(5) for quarter ended 31-Dec-2025; no rematerialisation requests.](https://nsearchives.nseindia.com/corporate/DOCMODE_09012026153219_Disclosure_Regulation74_SebiDPReg_Docmode.pdf) |
| 9 January 2026 - Reconciliation report for quarter ended 31-Dec-2025; issued capital 3,142,800 shares; CS resigned, interim compliance officer appointed. | [Updates 9 January 2026 - Reconciliation report for quarter ended 31-Dec-2025; issued capital 3,142,800 shares; CS resigned, interim compliance officer appointed.](https://nsearchives.nseindia.com/corporate/DOCMODE_09012026164431_Disclosure_ReconciliationofShareCapitalAudit_docmode.pdf) |
| 5 Feb - Board meeting Feb 14, 2026 to approve Q3 unaudited results (Dec 31, 2025); trading window closed. | [Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 31St December 2025 5 Feb - Board meeting Feb 14, 2026 to approve Q3 unaudited results (Dec 31, 2025); trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/299d25a9-6787-4bd2-9ec0-822c93eea138.pdf) |
| 3 December 2025 - Approved unaudited H1 results (30 Sep 2025): Revenue Rs1,784.68 lakh; loss Rs9.13 lakh; limited review. | [Outcome of Board Meeting 3 December 2025 - Approved unaudited H1 results (30 Sep 2025): Revenue Rs1,784.68 lakh; loss Rs9.13 lakh; limited review.](https://nsearchives.nseindia.com/corporate/DOCMODE_03122025190821_OutcomeofBM_FinancialResults_final.pdf) |
| 29 Apr - Company confirms it is not a Large Corporate as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Company confirms it is not a Large Corporate as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/83cecb19-a2bd-4231-93d7-99f8987913ba.pdf) |
| 29 Apr - Company confirms it is not a Large Corporate as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Company confirms it is not a Large Corporate as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/83cecb19-a2bd-4231-93d7-99f8987913ba.pdf) |
| 14 Jan - Compliance Certificate under regualtion 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Jan - Compliance Certificate under regualtion 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6e7ef4b5-e208-4182-ba78-5df659161873.pdf) |
| 14 Feb - Q3 FY26 standalone unaudited results: revenue Rs965.38 lakh, profit Rs17.77 lakh; board approved 14 Feb 2026. | [Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025 14 Feb - Q3 FY26 standalone unaudited results: revenue Rs965.38 lakh, profit Rs17.77 lakh; board approved 14 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/20e5f5a4-edbb-46cd-9ab1-573005f3942a.pdf) |
| 14 Feb - Approved IND-AS unaudited Q3 results for quarter ended 31-Dec-2025: revenue Rs.965.38 lakh, PAT Rs.17.77 lakh. | [Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015. 14 Feb - Approved IND-AS unaudited Q3 results for quarter ended 31-Dec-2025: revenue Rs.965.38 lakh, PAT Rs.17.77 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af7cb876-fdea-44c2-85a3-f3bf5d473adc.pdf) |
| 11 Apr - Compliances certificate under Reg74(5) of SEBI(DP) Regulations, 2018 for the quarter ended ended 31-03-2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Apr - Compliances certificate under Reg74(5) of SEBI(DP) Regulations, 2018 for the quarter ended ended 31-03-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fbcb4388-daba-40c3-8583-91159e0486be.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_27918_DHTL_2024_2025_A_2628295_29082025194259.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25363_DHTL_2023_2024_3108202413945.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/63c5be0e-1e55-435f-9d47-1753771d10a3.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/999b7747-356f-4b88-8d0f-386bbf1dde49.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/78c7fc4c-3afb-43d2-8be0-5a0aece14633.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/50cee80c-2a14-4508-82fe-8f41145b00f4.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524548/72926524548.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524548/68148524548_01_01_21.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524548/5245480319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524548/5245480318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:15:56.794Z.